Development of AAV serotype-specific ELISAs using novel monoclonal antibodies
- 31 March 2007
- journal article
- Published by Elsevier BV in Journal of Virological Methods
- Vol. 140 (1-2), 17-24
- https://doi.org/10.1016/j.jviromet.2006.10.005
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Intranasal Vaccination with Recombinant Adeno-Associated Virus Type 5 against Human Papillomavirus Type 16 L1Journal of Virology, 2006
- Impact of Capsid Conformation and Rep-Capsid Interactions on Adeno-Associated Virus Type 2 Genome PackagingJournal of Virology, 2006
- Green Fluorescent Protein-Tagged Adeno-Associated Virus Particles Allow the Study of Cytosolic and Nuclear TraffickingJournal of Virology, 2005
- Clades of Adeno-Associated Viruses Are Widely Disseminated in Human TissuesJournal of Virology, 2004
- Immune responses to adeno-associated virus and its recombinant vectorsGene Therapy, 2003
- Adenovirus-Facilitated Nuclear Translocation of Adeno-Associated Virus Type 2Journal of Virology, 2002
- Reduced prevalence of serum antibodies against adeno-associated virus type 2 in patients with adult T-cell leukaemia lymphomaJournal of Medical Virology, 2001
- Titration of AAV-2 particles via a novel capsid ELISA: packaging of genomes can limit production of recombinant AAV-2Gene Therapy, 1999
- In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral VectorScience, 1996
- Characterization of 911: A New Helper Cell Line for the Titration and Propagation of Early Region 1-Deleted Adenoviral VectorsHuman Gene Therapy, 1996